ID   RB143
AC   CVCL_5I30
SY   Rb143
DR   Kerafast; EEE002
DR   Wikidata; Q54949286
RX   PubMed=20371623;
RX   PubMed=23233783;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex3-17del; Zygosity=Unspecified (PubMed=20371623).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
RX   PubMed=20371623; DOI=10.1096/fj.09-152546; PMCID=PMC2909289;
RA   Theodoropoulou S., Kolovou P.E., Morizane Y., Kayama M., Nicolaou F.,
RA   Miller J.W., Gragoudas E.S., Ksander B.R., Vavvas D.G.;
RT   "Retinoblastoma cells are inhibited by aminoimidazole carboxamide
RT   ribonucleotide (AICAR) partially through activation of AMP-dependent
RT   kinase.";
RL   FASEB J. 24:2620-2630(2010).
//
RX   PubMed=23233783; PMCID=PMC3519375;
RA   Bejjani A., Choi M.R., Cassidy L., Collins D.W., O'Brien J.M.,
RA   Murray T., Ksander B.R., Seigel G.M.;
RT   "RB116: an RB1+ retinoblastoma cell line expressing primitive
RT   markers.";
RL   Mol. Vis. 18:2805-2813(2012).
//